>> 全站文章索引 >> 第27页:
Ketamine Depresses Myocardial Contractility as Evaluated by the Preload Recruitable Stroke Work Relationship in Chronically Instrumented Dogs with Autonomic Nervous System Blockade - [Pagel, Paul S.; Kampine, John P.; Schmeling, William T.; Warltier, David C.]
METHYLPHENIDATE IN STROKE PATIENTS WITH DEPRESSION - [Johnson, Maria Lee; Roberts, Michael D.; Ross, Angelita R.; Witten, Celia M.]
Longitudinal Study of Regional Cerebral Blood Flow Changes in Depression After Stroke - [Yamaguchi, Shuhei M.; Kobayashi, Shotai M.; Koide, Hiromi M.; Tsunematsu, Tokugoro M.]
Different Linkage of Depression to Hypercortisolism Early Versus Late After Stroke: A 3-Year Longitudinal Study - [Astrom, Monica M.; Olsson, Tommy M.; Asplund, Kjell M.]
Major Depression in Stroke Patients: A 3-Year Longitudinal Study - [Astrom, Monica M.; Adolfsson, Rolf M.; Asplund, Kjell M.]
The Influence of Depression, Social Activity, and Family Stress on Functional Outcome After Stroke - [Angeleri, Franco M.; Angeleri, Vita Aurora; Foschi, Nicoletta M.; Giaquinto, Salvatore M.; Nolfe, Giuseppe Ph]
Depression after stroke - [Castillo, Carlos S.; Robinson, Robert G.]
Are There Two Depressive Syndromes after Stroke - [MORRIS, P. HILIP; SHIELDS, R. OBERT; HOPWOOD, M. ALCOLM; ROBINSON, R. OBERT; RAPHAEL, B. EVERLEY]
Mesial Temporal Cortex Hypoperfusion Is Associated With Depression in Subcortical Stroke - [Grasso, M. G.; Pantano, P. MD; Ricci, M. MD; Intiso, D. F.; Pace, A. MD; Padovani, A. MD; Orzi, F. MD; Pozzilli, C. MD; Lenzi, G. L.]
Longitudinal Assessment of Depression and Cognitive Impairment Following Stroke - [DOWNHILL, J. ACK; ROBINSON, R. OBERT]
ST Segment Depression Detected by Continuous Electrocardiography in Patients With Acute Ischemic Stroke or Transient Ischemic Attack - [Mcdermott, Mary Mc; Lefevre, Frank M.; Arron, Martin M.; Martin, Gary J.; Biller, Jose M.]
Prevalence of Depression After Stroke: The Perth Community Stroke Study - [Burvill, P. W.; Johnson, G. A.; Jamrozik, K. D.; Anderson, C. S.; Stewart-Wynne, E. G.; Chakera, T. M.]
Poststroke Depression: Is There a Pathoanatomic Correlate for Depression in the Postacute Stage of Stroke - [Herrmann, Manfred M.; Bartels, Claudius M.; Schumacher, Martin M.; Wallesch, Claus- W.]
Diagnosing Depression After Stroke - [BLACK, K. EVIN]
How nurses in a stroke rehabilitation unit attempt to meet the psychological needs of patients who become depressed following a stroke - [Bennett, Beverley B.]
Validation of a Depression Screening Measure for Stroke Inpatients - [Rybarczyk, Bruce Ph; Winemiller, David R.; Lazarus, Lawrence W.; Haut, Allyson Ph; Hartman, Carolyn M.]
Generalized Anxiety and Depression: Assessment Over 2 Years After Stroke - [Schultz, Susan K.; Castillo, Carlos S.; Kosier, J. Todd; Robinson, Robert G.]
Assessment of Depression in Patients With Brain Pathology: The Case of Stroke - [Spencer, Kristie A.; Tompkins, Connie A.; Schulz, Richard]
Depression After Stroke: Results of the FINNSTROKE Study - [Kotila, Mervi M.; Numminen, Heikki M.; Waltimo, Olli M.; Kaste, Markku M.]
Depression and its relation to lesion location after stroke - [MacHale, Siobhan M.; O, Rourke Suzanne; Wardlaw, Joanna M.; Dennis, Martin S.]
The Sunnybrook Stroke Study: A Prospective Study of Depressive Symptoms and Functional Outcome - [Herrmann, N. MD; Black, S. E.; Lawrence, J. RN; Szekely, C. MA; Szalai, J. P.]
Depressive Symptoms and Increased Risk of Stroke Mortality Over a 29-Year Period - [Everson, Susan A.; Roberts, Robert E.; Goldberg, Debbie E.; Kaplan, George A.]
Minor Depression After Stroke - [Paradiso, Sergio M.; Robinson, Robert G.]
Frequency, phenomenology and anatomical-clinical correlates of major post-stroke depression - [GAINOTTI, G.; AZZONI, A.; MARRA, C.]
The Crucial Role of Frontostriatal Circuits for Depressive Disorders in the Postacute Stage After Stroke - [Beblo, Thomas Ph; Wallesch, Claus W.; Herrmann, Manfred M.]
Nortriptyline Versus Fluoxetine in the Treatment of Depression and in Short-Term Recovery After Stroke: A Placebo-Controlled, Double-Blind Study - [Robinson, Robert G.; Schultz, Susan K.; Castillo, Carlos M.; Kopel, Teresa M.; Kosier, J. Todd; Newman, R. Mark; Curdue, Kathryn M.; Petracca, Gustavo M.; Starkstein, Sergio E.]
Functional and Neuroanatomic Correlations in Poststroke Depression: The Sunnybrook Stroke Study - [Singh, Anu M.; Black, Sandra E.; Herrmann, Nathan M.; Leibovitch, Farrell S.; Ebert, Patricia L.; Lawrence, Joanne R.; Szalai, John P.]
Symptoms of Depression as a Prospective Risk Factor for Stroke - [Jonas, Bruce S.; Mussolino, Michael E.]
Depression after stroke and lesion location: a systematic review - [Carson, Alan J.; MacHale, Siobhan; Allen, Kathryn; Lawrie, Stephen M.; Dennis, Martin; House, Allan; Sharpe, Michael]
Depression and Other Determinants of Values Placed on Current Health State by Stroke Patients - [Bosworth, Hayden B.; Horner, Ronnie D.; Edwards, Lloyd J.; Matchar, David B.; for, V. ASt]
Stroke, vascular risk factors and depression: Cross-sectional study in a UK Caribbean-born population - [STEWART, R.; PRINCE, M.; RICHARDS, M.; BRAYNE, C.; MANN, A.]
Mortality at 12 and 24 Months After Stroke May Be Associated With Depressive Symptoms at 1 Month - [House, Allan D.; Knapp, Peter R.; Bamford, John M.; Vail, Andy M.]
Prospective Study of Depressive Symptoms and Risk of Stroke Among Japanese - [Ohira, Tetsuya M.; Iso, Hiroyasu M.; Satoh, Shinji M.; Sankai, Tomoko M.; Tanigawa, Takeshi M.; Ogawa, Yuka M.; Imano, Hironori M.; Sato, Shinichi M.; Kitamura, Akihiko M.; Shimamoto, Takashi M.]
Relation between depression after stroke, antidepressant therapy, and functional recovery - [Gainotti, G.; Antonucci, G.; Marra, C.; Paolucci, S.]
Depressive Disorder, Dysthymia, and Risk of Stroke: Thirteen-Year Follow-Up From the Baltimore Epidemiologic Catchment Area Study - [Larson, Sharon L.; Owens, Pamela L.; Ford, Daniel M.; Eaton, William Ph]
Magnetic Resonance Imaging Correlates of Depression After Ischemic Stroke - [Vataja, Risto M.; Pohjasvaara, Tarja M.; Leppavuori, Antero M.; Mantyla, Riitta M.; Aronen, Hannu Juhani; Salonen, Oili M.; Kaste, Markku M.; Erkinjuntti, Timo M.]
Higher Incidence of Falls in Long-Term Stroke Survivors Than in Population Controls - [Jorgensen, Lone Ph; Engstad, Torgeir M.; Jacobsen, Bjarne K.]
Determinants and consequences of post-stroke depression - [Gainotti, Guido; Marra, Camillo]
Therapeutic effects of milnacipran, a serotonin and noradrenaline reuptake inhibitor, on post-stroke depression - [Kimura, M. a.; Kanetani, K. b.; Imai, R. c.; Suzuki, H. a.; Isayama, K. b.; Endo, S. a.]
Personality and Vulnerability to Depression in Stroke Patients - [Aben, Ivo M.; Denollet, Johan Ph; Lousberg, Richel Ph; Verhey, Frans M.; Wojciechowski, Franz Ph; Honig, Adriaan M.]
Cognitive Behavioral Psychotherapy for Depression Following Stroke - [Lincoln, N. B.; Flannaghan, T. MPhil]
Atorvastatin causes depressor and sympatho-inhibitory effects with upregulation of nitric oxide synthases in stroke-prone spontaneously hypertensive rats - [Kishi, Takuya; Hirooka, Yoshitaka; Mukai, Yasushi; Shimokawa, Hiroaki; Takeshita, Akira]
A comparative study into the one year cumulative incidence of depression after stroke and myocardial infarction - [Aben, I.; Verhey, F.; Strik, J.; Lousberg, R.; Lodder, J.; Honig, A.]
Association of Exercise-Induced, Silent ST-Segment Depression With the Risk of Stroke and Cardiovascular Diseases in Men - [Kurl, S. MD; Laukkanen, J. A.; Tuomainen, T.; Rauramaa, R. MD; Lakka, T. A.; Salonen, R. MD; Eranen, J. MD; Sivenius, J. MD; Salonen, J. T.]
Post-Stroke and Clinically-Defined Vascular Depression in Geriatric Rehabilitation Patients - [Mast, Benjamin T.; MacNeill, Susan E.; Lichtenberg, Peter A.]
Depressive symptoms after stroke and relationship with dementia - [Verdelho, A. MD; Henon, H. MD; Lebert, F. MD; Pasquier, F. MD; Leys, D. MD]
Self-Reported Depression and Use of Antidepressants After Stroke: A National Survey - [Eriksson, Marie M.; Asplund, Kjell M.; Glader, Eva- Lotta; Norrving, Bo M.; Stegmayr, Birgitta Ph; Terent, Andreas M.; Asberg, Kerstin Hulter; Wester, Per- Olov; for, The Riks-]
Family Caregivers of Stroke Survivors: Characteristics of Caregivers at Risk for Depression - [Grant, Joan S.; Weaver, Michael; Elliott, Timothy R.; Bartolucci, Alfred A.; Giger, Joyce Newman]
Performance of the PHQ-9 as a Screening Tool for Depression After Stroke - [Williams, Linda S.; Brizendine, Edward J.; Plue, Laurie M.; Bakas, Tamilyn D.; Tu, Wanzhu Ph; Hendrie, Hugh M.; Kroenke, Kurt M.]
Depression Among Caregivers of Stroke Survivors - [Berg, Anu Lic; Palomaki, Heikki M.; Lonnqvist, Jouko M.; Lehtihalmes, Matti Lic; Kaste, Markku M.]
Management of Depression After Stroke: A Systematic Review of Pharmacological Therapies - [Hackett, Maree L.; Anderson, Craig S.; House, Allan O.]
Frequency of Depression After Stroke: A Systematic Review of Observational Studies - [Hackett, Maree L.; Yapa, Chaturangi B.; Parag, Varsha M.; Anderson, Craig S.]
Predictors of Depression after Stroke: A Systematic Review of Observational Studies - [Hackett, Maree L.; Anderson, Craig S.]
Depression and Other Mental Health Diagnoses After Stroke Increase Inpatient and Outpatient Medical Utilization Three Years Poststroke - [Ghose, Sushmita Shoma; Williams, Linda S.; Swindle, Ralph W.]
The Impact of Poststroke Depression on Healthcare Use by Veterans With Acute Stroke - [Jia, Huanguang Ph; Damush, Teresa M.; Qin, Haijing M.; Ried, L. Douglas; Wang, Xinping Ph; Young, Linda J.; Williams, Linda S.]
Prevalence of Depression and Use of Antidepressant Medication at 5-Years Poststroke in the North East Melbourne Stroke Incidence Study - [Paul, Seana L.; Dewey, Helen M.; Sturm, Jonathan W.; Macdonell, Richard A.; Thrift, Amanda G.]
Depressive Symptoms and Risk of Stroke: The Framingham Study - [Salaycik, Kimberly J.; Kelly-Hayes, Margaret Ed; Beiser, Alexa Ph; Nguyen, Anh- Hoa; Brady, Stephen M.; Kase, Carlos S.; Wolf, Philip A.]
Effect of antenatal exposure to paroxetine (Paxil) on growth and physical maturation of mice offspring - [William F. Rayburn 1 2 *, Christina L. Gonzalez 1 2, H. Dix Christensen 1 2, Thomas C. Kupiec 3, Jesse A. Jacobsen 2, Jeffrey D. Stewart 1 AD:1Department of Obstetrics and Gynecology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma2]
Inhibition of hippocampal 5-HT synthesis by fluoxetine and paroxetine: Evidence for the involvement of both 5-HT1A and 5-HT1B/D autoreceptors - [Cheryl L. Barton, Peter H. Hutson * Merck Sharp and Dohme, Neuroscience Research Centre, Terlings Park, Harlow Essex, U.K.]
Venlafaxine: Discrepancy between in vivo 5-HT and NE reuptake blockade and affinity for reuptake sites - [Jean-Claude Bé?que *, Claude De Montigny, Pierre Blier, Guy Debonnel AD:Neurobiological Psychiatry Unit, Department of Psychiatry, McGill University, Montréal, Québec, Canada]
Binding of S-citalopram and paroxetine discriminates between species - [Betina Elfving *, Ove Wiborg AD:Laboratory of Molecular Neurobiology, Department of Biological Psychiatry, Aarhus Psychiatric University Hospital, Risskov, Denmark]
Acute and repeated administration of fluoxetine, citalopram, and paroxetine significantly alters the activity of midbrain dopamine neurons in rats: An in vivo electrophysiological study - [Yoshimoto Sekine 1, Katsuaki Suzuki 1, P. Veeraraghavan Ramachandran 2, Thomas P. Blackburn 3, Charles R. Ashby JR. 4 * AD:1Department of Psychiatry and Neurology, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan2Department of Chemistry]
Quantitative determination of paroxetine and its 4-hydroxy-3-methoxy metabolite in plasma by high-performance liquid chromatography - [Mireia Segura 1 2, Jordi Ortu?o 1, Magí Farré 1 3, Roberta Pacifici 4, Simona Pichini 4, Jesús Joglar 5, Jordi Segura 1 2, Rafael de la Torre 1 2 * AD:1Institut Municipal d]
A comparison of fluvoxamine, fluoxetine, sertraline and paroxetine examined by observational cohort studies - [Fiona J. Mackay, Nicholas R. Dunn, Lynda V. Wilton, Gillian L. Pearce, Shayne N. Freemantle, Ronald D. Mann * AD:Drug Safety Research Unit, Bursledon Hall, Southampton, UK]
Different regional distribution of the 5-HT reuptake complex, the 5-HT2A receptors and their second messenger IP3 in human brain - [Pilar Rosel 1, Belén Arranz 2, Miguel Oros 1, Julio Vallejo 3, Luis San 2, Jan Marcusson 4, Miguel A. Navarro 1 AD:1Hormone Unit, Ciutat Sanitaria i Universitaria de Bellvitge, Barcelona, Spain2Benito Menni, Mental Health Care Institute, Barcelona, Spain]
Tolerability of paroxetine in Parkinson's disease: A prospective study - [Silvana Tesei, MD, Angelo Antonini, MD *, Margherita Canesi, MD, Anna Zecchinelli, MD, Claudio B. Mariani, MD, Gianni Pezzoli, MD AD:Parkinson Center, Department of Neuroscience, Istituti Clinici di Perfezionamento, Milan, Italy]
Enantiomeric analysis of (3S,4R)-4-(4-fluorophenyl)- 3-hydroxymethyl-1-methylpiperidine by 19F NMR spectroscopy - [Hana Navrátilová * AD:Department of Organic Chemistry, Faculty of Science, Masaryk University, 611 37 Brno, Czech Republic]
Quantitative 1H NMR method for the routine spectroscopic determination of enantiomeric purity of active pharmaceutical ingredients fenfluramine, sertraline, and paroxetine - [Jonathon S. Salsbury *, Paul K. Isbester AD:Albany Molecular Research, Incorporation, Albany, NY 12212-5098, USA]
Separation of five recently commercialized selective serotonin reuptake inhibitor antidepressants by capillary electrophoresis - [Vincenzo Pucci 1, Salvatore Fanali 2, Cesare Sabbioni 1, Maria Augusta Raggi * AD:1University of Bologna, Department of Pharmaceutical Sciences, Via Belmeloro 6, 40126 Bologna, Italy; Fax: +39 051 20997342National Council of Research, Institute of Chemist]
Development of a Capillary Zone Electrophoretic method to determine six antidepressants in their pharmaceutical preparations. Experimental design for evaluating the ruggedness of method - [Juana Rodríguez Flores *, Juan J. Berzas Nevado, Ana M. Contento Salcedo, Maria P. Cabello Díaz AD:Department of Analytical Chemistry and Foods Technology. UCLM 13071, Ciudad Real, Spain.]
Evaluation of the neuropharmacodynamics of paroxetine in vivo utilizing microdialysis - [Atulkumar Ramaiya 1, James H. Johnson 2, H. Thomas Karnes 1 * AD:1Department of Pharmacy & Pharmaceutics, Medical College of Virginia/Virginia Commonwealth University, P.O. Box 980533, Richmond, Virginia 23298-980533.2Department of Anatomy, Medical Colleg]
Antidepressant-induced regulation of 5-HT1b mRNA in rat dorsal raphe nucleus reverses rapidly after drug discontinuation - [J.P. Anthony, T.J. Sexton, J.F. Neumaier * Department of Psychiatry and Behavioral Sciences and Harborview Medical Center, University of Washington, Seattle]
Stable isotope dilution negative ion chemical ionization gas chromatography-mass spectrometry for the quantitative analysis of paroxetine in human plasma - [Hans J?rg Leis *, Werner Windischhofer, Günther Raspotnig, Günter Fauler AD:University Children]
A double-blind comparison of the efficacy and safety of paroxetine and imipramine in the treatment of depression with dementia - [Cornelius L. E. Katona, Professor of Psychiatry of the Elderly 1 *, Brian N. Hunter 2, Julia Bray 2 AD:1Department of Psychiatry and Behavioural Sciences,UCL Medical School, London, UK2SmithKline Beecham Pharmaceuticals, New Frontiers Science Park (South)]
Comparison study of venlafaxine and paroxetine for the treatment of depression in elderly Chinese inpatients - [Jen-Ping Hwang, Cheng-Hung Yang, Shih-Jen Tsai * AD:Department of Psychiatry, Taipei Veterans General Hospital, and Division of Psychiatry, School of Medicine, National Yang-Ming University, Taipei, Taiwan, Republic of China]
Withdrawal symptoms from paroxetine - [Colin Milliken 1, Stephen J. Cooper 2 * AD:1Department of Psychiatry, Belfast City Hospital, Belfast, UK2Department of Mental Health, The Queen]
Drug Safety Monitoring of 12692 Patients Treated with Fluoxetine - [J. GUY EDWARDS 1, WILLIAM H. W. INMAN 2, LYNDA WILTON 3, GILLIAN L. PEARCE 3, KIYOSHI KUBOTA 4 AD:1University of Southampton, Faculty of Medicine, Health and Biological Sciences, Department of Psychiatry, Royal South Hants Hospital, Southampton SO14 0YG,]
The Effect of Paroxetine and Dothiepin on Subjective Sleep in Depressed Patients - [JOHN S. KERR *, DIANE B. FAIRWEATHER, IAN HINDMARCH AD:HPRU, University of Surrey, Milford Hospital, Godalming, Surrey, GU7 1UF, UK]
Effectiveness of Fluvoxamine and Paroxetine in Major Depressives with Psychotic Features - [EMILIO SACCHETTI 1 *, GIOVANNI CONTE 2, LAURA GUARNERI 3, ALESANDRO CALZERONI 2, MARA BERTINI 4, ADELAIDE PANARIELLO 4 AD:1Institute of Psychiatry, Second Chair Brescia University School of Medicine, Brescia, Italy2ASSL 39, University Department of Mental]
Selective serotonin reuptake inhibitors and withdrawal symptoms: a review of the literature - [Fran?ois Therrien 1, John S. Markowitz 2 * AD:1Faculté de Pharmacie, Université de Montréal, 2900, Boul. Edouard-Montpetit, C.P. 6128, succursale A, Montréal, Québec, Canada, H3C 3J72Department of Pharmacy Practice, Institute of Psychiatry, Medical U]
Setting New Standards for the Pharmacological Treatment of Panic Disorder - [R. KUMAR * AD:SmithKline Beecham Pharmaceuticals, New Frontiers Science Park (South), Third Avenue, Harlow, Essex CM19 5AW, UK]
Relationship between clinical effects, serum drug concentration, and concurrent drug interactions in depressed patients treated with citalopram, fluoxetine, clomipramine, paroxetine or venlafaxine - [C. Charlier 1 *, E. Pinto 2, M. Ansseau 2, G. Plomteux 1 AD:1University of Liège, Toxicology Laboratory, CHU Sart Tilman, B-4000 Liège, Belgium2University of Liège, Psychiatric Unit, CHU Sart Tilman, B-4000 Liège, Belgium]
A review of the safety of selective serotonin reuptake inhibitors during pregnancy - [David J. Goldstein 1 2 3 *, Karen Sundell 1 AD:1Neuroscience Division, Lilly Research Laboratories, Lilly Corporate Center-1730, Indianapolis, IN 46285, USA2Department of Pharmacology and Toxicology, Indiana University Medical School, Indianapolis, IN, US]
Treatment-emergent behavioural side effects with selective serotonin re-uptake inhibitors in adults with learning disabilities - [A. B. Biswas 1 *, S. Bhaumik 1, D. Branford 2 AD:1University of Leicester, & Leicestershire and Rutland Healthcare NHS Trust, Frith Hospital, Groby Road, Leicester LE3 9QF, UK2Southern Derbyshire Mental Health Trust, Kingsway Hospital, Derby DE22 3LZ, UK]
Tianeptine and paroxetine in major depressive disorder, with a special focus on the anxious component in depression: an international, 6-week double-blind study - [Jean Pierre Lepine 1 *, Carlo Altamura 2, Marc Ansseau 3, Jose Luis Ayuso Gutierrez 4, Istvan Bitter 5, Malcolm Lader 6, Lionel Waintraub 7 * AD:1Service de Psychiatrie, H魀ital Fernand Widal, 200, rue du Faubourg St Denis, 75745 Paris Cedex 10, France2Un]
Mirtazapine and paroxetine: a drug-drug interaction study in healthy subjects - [F. J. L. Ruwe 1, R. A. Smulders 3, H. J. Kleijn 2, H. L. A. Hartmans 3, J. M. A. Sitsen 1 * AD:1Clinical Development Department, NV Organon, PO Box 20, 5340 BH Oss, The Netherlands2Department of Drug Metabolism & Kinetics, NV Organon, PO Box 20, 5340 BH O]
Cytochrome P450 2D6 genotype does not predict SSRI (fluoxetine or paroxetine) induced hyponatraemia - [Catherine A. M. Stedman 1, Evan J. Begg 1 *, Martin A. Kennedy 2, Rebecca Roberts 2, Timothy J. Wilkinson 3 AD:1Department of Clinical Pharmacology, Christchurch Hospital, Christchurch School of Medicine, Christchurch, New Zealand2Department of Pathology,]
Seasonal variations in the binding of [3H]paroxetine to the platelet serotonin transporter sites in African-American cocaine-dependent patients and healthy volunteers - [Ashwin A. Patkar 1 *, Wade H. Berrettini 2, Allan Lundy 1, Heather W. Murray 1, Kevin P. Hill 1, Michael J. Vergare 1, Stephen P. Weinstein 1 AD:1Division of Substance Abuse Programs, Department of Psychiatry and Human Behavior, Thomas Jefferson Universit]
Use of paroxetine for the treatment of depression and anxiety disorders in the elderly: a review - [Michel Bourin 1 2 * AD:1Neurobiology of Anxiety and Depression, Faculty of Medicine, Nantes, France2Neurochemical Research Unit, University of Alberta, Edmonton, Alberta, Canada]
A placebo controlled investigation into the effects of paroxetine and mirtazapine on measures related to car driving performance - [F. Ridout *, R. Meadows, S. Johnsen, I. Hindmarch AD:HPRU Medical Research Centre, University of Surrey, Egerton Road, Guildford GU2 7XP, UK]
Differential period of onset of action of fluvoxamine, paroxetine and milnacipran for depression - [Shigeru Morishita 1 *, Seizaburo Arita 2 AD:1Department of Psychiatry, Kawasaki Medical School, Kurashiki, Okayama, Japan2Department of Mathematics, Kansai Medical School, Hirakata, Osaka, Japan]
Induction of mania in depression by paroxetine - [Shigeru Morishita 1 *, Seizaburo Arita 2 AD:1Department of Psychiatry, Kawasaki Medical School, Kurashiki, Okayama, Japan2Department of Mathematics, Kansai Medical School, Hirakata, Osaka, Japan]
Paroxetine in the treatment of depressed patients with haematological malignancy: an open-label study - [Chi-Un Pae 1, Yoo-Jin Kim 2, Wang-Youn Won 1, Hee-Je Kim 2, Seok Lee 2, Chang-Uk Lee 1, Soo-Jung Lee 1, Dong-Wook Kim 2, Chul Lee 1 *, Woo-Sung Min 2, Chun-Choo Kim 2, In-Ho Paik 1, Alessandro Serretti 3 AD:1Department of Psychiatry, Kangnam St Mary]
Comorbid cannabis use and panic disorder: short term and long term follow-up study - [Pinhas N. Dannon 1 2 3 *, Katherine Lowengrub 1 3, Revital Amiaz 2, Leon Grunhaus 2, Moshe Kotler 3 AD:1Rehovot Community Mental Health Care and Rehabilitation Centre, Israel2Chaim Sheba Med Centre, Psychiatry Ward, Tel Hashomer, Israel3Beer Ya]
Paroxetine treatment of delusional disorder, somatic type - [Hiroshi Hayashi, Shingo Oshino, Junichi Ishikawa, Shinobu Kawakatsu, Koichi Otani * AD:Department of Neuropsychiatry, Yamagata University School of Medicine, 2-2-2 Iidanishi, Yamagata 990-9585, Japan]
Serum disposition of sertraline, N-desmethylsertraline and paroxetine: a pharmacokinetic evaluation of repeated drug concentration measurements during 6 months of treatment for major depression - [Margareta Reis 1 2 *, Anna ?berg-Wistedt 3, Hans ?gren 4, Peter H?glund 2, Ann-Charlotte ?kerblad 5, Finn Bengtsson 5 AD:1Department of Medicine and Care, Division of Clinical Pharmacology, Faculty of Health Sciences, Link?ping University, Link?ping, Swed]
Efficacy of Venlafaxine ER in patients with social anxiety disorder: a double-blind, placebo-controlled, parallel-group comparison with paroxetine - [Christer Allgulander 1 *, Richard Mangano 2, Jun Zhang 2, Alv A. Dahl 3, Ulla Lepola 4, Ingemar Sj?din 5, Gerard Emilien 6, for the SAD 388 Study Group AD:1Karolinska Institutet, The Neurotec Department, Section of Psychiatry, Stockholm, Sweden2Wyeth Rese]
Differential effects of fluvoxamine, paroxetine and milnacipran for depression, especially with regard to age - [Shigeru Morishita 1 2 *, Seizaburo Arita 2 AD:1Depression Prevention Medical Center, Kyoto Jujo Hospital, Kyoto, Japan2Department of Mathematics, Kansai Medical School, Hirakata, Osaka, Japan]
Post-treatment emergent adverse events in depressed patients following treatment with milnacipran and paroxetine - [P. Vandel 1, D. Sechter 1, E. Weiller 2, N. Pezous 2, F. Cabanac 2, A. Tournoux 2, E. Panconi 2 AD:1Service de Psychiatrie et Psychologie Médicale, CHU St Jacques, Besan?on, France2Institut De Recherche Pierre Fabre, Boulogne, France]
A Formal Synthesis of (-)-Paroxetine by Enantioselective Ring Enlargement of a Trisubstituted Prolinol - [Janine Cossy 1 *, Olivier Mirguet 1, Domingo Gomez Pardo 1 *, Jean-Roger Desmurs 2 AD:1Laboratoire de Chimie Organique associé au CNRS, ESPCI, 10 rue Vauquelin, 75231 Paris Cedex 05, France, Fax: (internat.) + 33-(0)1407946602Rhodia, 190 avenue Thiers, 6]
分页: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 [27] 28 29 30 31 32 33 34 35 36 37 38 39 40
41 42 43 44 45 46 47 48 49 50 |